Target intelligence / Profile preview

Angiogenesis regulation via exerkines

Molecular classification
Other (exerkines are a heterogeneous group of molecules, not a single molecular entity or receptor)
01

Overview

"Angiogenesis regulation via exerkines" does not refer to a single molecule or receptor but rather describes the process by which **exerkines**—a diverse group of humoral factors released in response to acute or chronic exercise—modulate the formation of new blood vessels. Exerkines include cytokines, peptides, and metabolites secreted from skeletal muscle and other organs during physical activity. Notable examples are interleukin‑6 (IL‑6) and fibroblast growth factor 21 (FGF21), both shown to influence metabolic adaptation, tissue regeneration, and vascular remodeling. For instance, FGF21 sensitivity in cardiac tissue is increased by endurance exercise, promoting myocardial angiogenesis and protecting against ischemic injury. The term itself is not a canonical target but an umbrella for multiple molecular mediators involved in exercise-induced physiological responses related to vascular health[1][2][3].

Other names
Exerkine-mediated angiogenesis regulationAngiogenesis via exerkinesExercise-induced angiogenic signaling
02

Mechanism of action

Exerkines act as messengers released during exercise that can promote or regulate the formation of new blood vessels (angiogenesis) in various tissues by modulating signaling pathways such as FGF21/FGF receptor/KLB axis and IL‑6/GLP‑1 axis[1].

03

Biological functions

Regulation of angiogenesisSignal transductionMetabolic adaptationCardioprotectionImmune modulation
04

Disease associations

Cardiovascular disease (including diabetic cardiomyopathy, cardiac fibrosis)Obesity-related metabolic diseasesOther (potentially cancer and other conditions where angiogenesis is relevant)
05

Biomarkers

Circulating levels of specific exerkines such as interleukin‑6 (IL‑6), fibroblast growth factor 21 (FGF21)

Beyond the preview

Go deeper on Angiogenesis regulation via exerkines.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Angiogenesis regulation via exerkines.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call